NDC properties for "adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2680743)
About this data
The tables show NDC propoerties for adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2680743
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2680743)
| BLA | BLA761058 |
|---|---|
| MMSL_CODE | BD40586 |
| RxCUI | 2680743 |
| SPL_SET_ID | 62f39a7c-00df-4519-a8d4-39bbd0a649ed |
| SPL_SET_ID | f9986706-9c75-4335-a54f-09d7716dbcef |
| VUID | 4043147 |
| Prescribable Synonym | adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML adalimumab-adbm 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-adbm 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-adbm 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2680743) |
NDC Properties
NDC Item 00597056012
| NDC 9 | 0597-0560 |
|---|---|
| NDC 10 | 0597-0560-12 |
| NDC Item | 00597056012 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0597-0560 |
NDC Item 00597056520
| NDC 9 | 0597-0565 |
|---|---|
| NDC 10 | 0597-0565-20 |
| NDC Item | 00597056520 |
| Packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0565 |
NDC Item 82009014622
| NDC 9 | 82009-146 |
|---|---|
| NDC 10 | 82009-146-22 |
| NDC Item | 82009014622 |
| Packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-146 |
NDC Item 82009014711
| NDC 9 | 82009-147 |
|---|---|
| NDC 10 | 82009-147-11 |
| NDC Item | 82009014711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-147 |
NDC Item 00597056012
| NDC 9 | 0597-0560 |
|---|---|
| NDC 10 | 0597-0560-12 |
| NDC Item | 00597056012 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0597-0560 |
NDC Item 00597056520
| NDC 9 | 0597-0565 |
|---|---|
| NDC 10 | 0597-0565-20 |
| NDC Item | 00597056520 |
| Packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0565 |
NDC Item 82009014622
| NDC 9 | 82009-146 |
|---|---|
| NDC 10 | 82009-146-22 |
| NDC Item | 82009014622 |
| Packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-146 |
NDC Item 82009014711
| NDC 9 | 82009-147 |
|---|---|
| NDC 10 | 82009-147-11 |
| NDC Item | 82009014711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-147 |
NDC Item 00597056012
| NDC 9 | 0597-0560 |
|---|---|
| NDC 10 | 0597-0560-12 |
| NDC Item | 00597056012 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0597-0560 |
NDC Item 00597056520
| NDC 9 | 0597-0565 |
|---|---|
| NDC 10 | 0597-0565-20 |
| NDC Item | 00597056520 |
| Packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0565 |
NDC Item 82009014622
| NDC 9 | 82009-146 |
|---|---|
| NDC 10 | 82009-146-22 |
| NDC Item | 82009014622 |
| Packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-146 |
NDC Item 82009014711
| NDC 9 | 82009-147 |
|---|---|
| NDC 10 | 82009-147-11 |
| NDC Item | 82009014711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-147 |
NDC Item 00597056012
| NDC 9 | 0597-0560 |
|---|---|
| NDC 10 | 0597-0560-12 |
| NDC Item | 00597056012 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 0597-0560 |
NDC Item 00597056520
| NDC 9 | 0597-0565 |
|---|---|
| NDC 10 | 0597-0565-20 |
| NDC Item | 00597056520 |
| Packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0597-0565 |
NDC Item 82009014622
| NDC 9 | 82009-146 |
|---|---|
| NDC 10 | 82009-146-22 |
| NDC Item | 82009014622 |
| Packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 82009-146 |
NDC Item 82009014711
| NDC 9 | 82009-147 |
|---|---|
| NDC 10 | 82009-147-11 |
| NDC Item | 82009014711 |
| Packaging | 0.4 mL in 1 SYRINGE |
| Packaging | 1 in 1 TRAY |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 82009-147 |